Esophageal Stent Alleviates Benign Strictures
|
By HospiMedica International staff writers Posted on 06 Mar 2014 |

Image: The WallFlex Nitinol esophageal stent (Photo courtesy of Boston Scientific).
A fully covered metal stent provides new treatment options for patients with benign narrowing of the esophagus.
The WallFlex esophageal stent is made of a nickel-titanium (Nitinol) wire braided construction that provides luminal patency in the presence of strictures or benign tumors. The stent is designed for gradual expansion, typically complete in 24-72 hours; it features a Permalume silicone coating that is designed to prevent tumor in-growth, seal concurrent esophageal fistulas, and help reduce food impaction. The WallFlex Stent also provides physicians with clear visualization during fluoroscopy, aiding in accurate placement, as well as progressive, step flared ends that assist in anchoring the stent within the esophageal lumen.
An additional feature is a Teflon coated polyester suture that enables easy removal for up to eight weeks, potentially saving patients from having to visit the hospital to undergo additional dilations. The WallFlex Esophageal Fully Covered Stent is a product of Boston Scientific (Natick, MA, USA), and has received the European Community CE marking of approval. The stent is not approved for the removal from malignant strictures and has not been approved in the United States for the treatment of refractory benign esophageal strictures.
“Building on the best of Boston Scientific's industry-leading stents, the expanded indication for the WallFlex Esophageal Fully Covered Stent demonstrates our commitment to physician needs and dedication to improving patient outcomes,” said David Pierce, president of endoscopy at Boston Scientific. “This enables physicians in the European Union to provide additional options for the treatment and management of patients suffering from benign esophageal strictures.”
“Fully covered esophageal stents are a valid therapeutic option in patients with benign refractory esophageal strictures,” said Javier Jimenez, MD, chief of the Endoscopy Department at Complejo Hospitalario de Navarra (Pamplona, Spain). “I use the WallFlex Esophageal Stent because its small profile and radiopacity facilitate accurate placement, the migration rate is low, and stent removal is usually easy.”
Benign esophageal strictures are a narrowing or tightening of the esophagus caused by scarring that cause swallowing difficulties. Strictures can be caused by or associated with gastroesophageal reflux disease (GERD), esophagitis, a dysfunctional lower esophageal sphincter, disordered motility, lye ingestion, or a hiatal hernia. Strictures can also form after esophageal surgery and other treatments such as laser therapy or photodynamic therapy (PDT). The primary treatment is dilation of the esophagus, which may need to be repeated after a period if the stricture recurs.
Related Links:
Boston Scientific
The WallFlex esophageal stent is made of a nickel-titanium (Nitinol) wire braided construction that provides luminal patency in the presence of strictures or benign tumors. The stent is designed for gradual expansion, typically complete in 24-72 hours; it features a Permalume silicone coating that is designed to prevent tumor in-growth, seal concurrent esophageal fistulas, and help reduce food impaction. The WallFlex Stent also provides physicians with clear visualization during fluoroscopy, aiding in accurate placement, as well as progressive, step flared ends that assist in anchoring the stent within the esophageal lumen.
An additional feature is a Teflon coated polyester suture that enables easy removal for up to eight weeks, potentially saving patients from having to visit the hospital to undergo additional dilations. The WallFlex Esophageal Fully Covered Stent is a product of Boston Scientific (Natick, MA, USA), and has received the European Community CE marking of approval. The stent is not approved for the removal from malignant strictures and has not been approved in the United States for the treatment of refractory benign esophageal strictures.
“Building on the best of Boston Scientific's industry-leading stents, the expanded indication for the WallFlex Esophageal Fully Covered Stent demonstrates our commitment to physician needs and dedication to improving patient outcomes,” said David Pierce, president of endoscopy at Boston Scientific. “This enables physicians in the European Union to provide additional options for the treatment and management of patients suffering from benign esophageal strictures.”
“Fully covered esophageal stents are a valid therapeutic option in patients with benign refractory esophageal strictures,” said Javier Jimenez, MD, chief of the Endoscopy Department at Complejo Hospitalario de Navarra (Pamplona, Spain). “I use the WallFlex Esophageal Stent because its small profile and radiopacity facilitate accurate placement, the migration rate is low, and stent removal is usually easy.”
Benign esophageal strictures are a narrowing or tightening of the esophagus caused by scarring that cause swallowing difficulties. Strictures can be caused by or associated with gastroesophageal reflux disease (GERD), esophagitis, a dysfunctional lower esophageal sphincter, disordered motility, lye ingestion, or a hiatal hernia. Strictures can also form after esophageal surgery and other treatments such as laser therapy or photodynamic therapy (PDT). The primary treatment is dilation of the esophagus, which may need to be repeated after a period if the stricture recurs.
Related Links:
Boston Scientific
Latest Surgical Techniques News
- Minimally Invasive Procedure Reduces Knee Osteoarthritis Pain
- Computer-Assisted Vacuum Thrombectomy System Cleared for Stroke Care
- Near-Infrared Exoscope Enables Real-Time Perfusion Assessment and Lymphatic Mapping in Open Surgery
- Expandable Lumbar Fusion System Gains FDA 510(k) Clearance
- 3D Map of Heart Electrical Wiring Aims to Guide Congenital Heart Repair
- New CAR T-Cell Therapy Enables Transplants in Hard-to-Match Kidney Patients
- CE-Marked Ultrasonic Shears Streamline Breast and Thyroid Surgery
- Small Cryoprobe Outperforms Forceps in Lung Biopsy Trial
- Natural Bypass Score May Guide Care in Chronic Coronary Blockages
- Navigation Instruments Cleared for Posterior Cervical Fusion Procedures
- Bioengineered Heart Patch Improves Cardiac Function in Advanced Heart Failure
- Fracture Plating System Combines Anatomical Fit with Streamlined Instrumentation
- Surgical Robotic System Gains CE Mark for Minimally Invasive Procedures
- Pink Noise Stimulation Approach Could Support Safer Anesthesia
- BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures
- Anesthesia-Sparing System Targets Faster Ureteral Stone Treatment
Channels
Artificial Intelligence
view channel
New AI ECG Tool Detects Early Heart Disease
Heart disease remains a leading cause of premature death, claiming almost 18 million lives each year. Early detection is crucial because timely intervention can change prognosis and conserve resources.... Read more
AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure
Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read moreCritical Care
view channel
Optical Brain Monitoring Predicts Neurodevelopmental Outcomes in Preterm Infants
Premature birth, defined as delivery before 37 weeks of gestation, increases the risk of language, motor, and cognitive delays, yet many late preterm infants receive limited follow-up. Clinicians currently... Read more
AI Tool Identifies Children With Pneumonia Requiring Hospital Care
Pneumonia is the leading infectious killer of children under five, causing nearly one million deaths each year. Early recognition of severe cases in primary care is difficult, and current international... Read more
AI Ultrasound System Improves Safety of Blood–Brain Barrier Opening
The blood–brain barrier (BBB) is a protective interface that prevents most drugs and diagnostic molecules from reaching brain tissue. This safeguard complicates treatment and monitoring of brain tumors... Read more
CE-Marked Smartphone AI Enables Autonomous Skin Cancer Assessment at Point of Care
Skin cancer is among the most common malignancies in Europe, with more than one million non-melanoma cases and over 100,000 melanoma diagnoses each year. Early detection is critical for improving outcomes,... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
AI Tool Screens for Primary Aldosteronism Using Routine EHR Data
Primary aldosteronism, an adrenal disorder that causes excess aldosterone and secondary hypertension, is frequently missed despite its association with cardiovascular complications. Underdiagnosis can... Read moreAI-Enabled ECG Software Predicts One-Year Atrial Fibrillation Risk
Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with increased risks of stroke, heart failure, and death. Detection remains challenging because AF is often asymptomatic... Read morePoint of Care
view channel
Handheld AI Device for Point-of-Care Skin Lesion Assessment Receives CE Mark
DermaSensor (Miami, FL, USA) has received a Class IIb CE Mark for its handheld DermaSensor device, marking the start of the company’s global expansion strategy. The certification demonstrates conformity... Read more
Portable Immunoassay System Advances Toward Point-of-Care Biomarker Testing
Proxim Diagnostics Corp. (Santa Clara, CA, USA) has announced that its Profile System, a handheld point-of-care immunoassay platform, has completed development. The milestone includes completion... Read more
Portable MRI System Accelerates Emergency Brain Imaging and Triage
Emergency departments frequently face delays accessing conventional magnetic resonance imaging (MRI) for patients with suspected neurological emergencies. Such waits can slow triage, prolong boarding,... Read more







